Vertex Pharmaceuticals, Inc.

( )
VRTX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 0.18%72.140.0%$2377.09m
NVAXNovavax, Inc. 0.00%178.51251.8%$1337.92m
SRNESorrento Therapeutics, Inc. 11.74%21.031.5%$1005.21m
GILDGilead Sciences, Inc. 0.72%69.001.0%$568.33m
AMGNAmgen, Inc. -1.05%238.171.3%$477.09m
BNTXBioNTech SE 3.99%76.900.0%$413.54m
REGNRegeneron Pharmaceuticals, Inc. -1.93%608.242.7%$403.31m
VRTXVertex Pharmaceuticals, Inc. -1.56%268.731.9%$369.46m
BIIBBiogen, Inc. -1.78%300.261.6%$363.67m
ILMNIllumina, Inc. -0.65%353.353.5%$342.14m
VXRTVaxart, Inc. 4.20%9.790.0%$308.62m
EBSEmergent BioSolutions, Inc. -0.19%130.416.4%$188.70m
IBIOiBio, Inc. 4.62%3.850.2%$174.19m
ALXNAlexion Pharmaceuticals, Inc. -1.36%101.882.0%$166.53m
SGENSeattle Genetics, Inc. -1.71%157.706.2%$160.68m

Company Profile

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.